XML 77 R59.htm IDEA: XBRL DOCUMENT v3.23.1

Investments accounted for using the equity method (Tables)

12 Months Ended

Dec. 31, 2022

Investments accounted for using the equity method

Schedule of investment in associate and percentage of equity interest held in associate

​

​	​	​	​	​	​	​
​	​	For the year ended
​	​	December 31,
​		2020		2021		2022
​		RMB’000		RMB’000		RMB’000
At beginning of year		115,124	​	172,757	​	184,907
Additions		60,000	​	—	​	—
Share of (losses)/gain of associate		(4,878)	​	12,150	​	25,291
Gain on dilution of interest in associate (Note 8)		2,511	​	—	​	—
​	​	172,757	​	184,907	​	210,198
Less: impairment loss allowance	​	—	​	—	​	(10,998)
At end of year		172,757	​	184,907	​	199,200

Schedule of Summarised financial information for associate

​

​	​	​	​	​	​	​
Summarised balance sheet	​	As at December 31,
​		2020		2021		2022
​	​	RMB’000	​	RMB’000	​	RMB’000
​	​	​	​	​	​	​
Total assets		423,148		1,075,852		1,686,575
Total liabilities		(60,650)		(682,979)		(1,230,475)
Net assets		362,498		392,873		456,100

​

​	​	​	​	​	​	​	​
Summarised income statement	​	For the year ended December 31,
​		2020		2021		2022
​	​	RMB’000	​	RMB’000	​	RMB’000
​	​	​	​	​	​	​	​
Operating income		51,690		96,372		144,762	​
Profit or loss from continuing operations		(13,473)		30,375		63,228	​
​	​	​	​	​	​	​	​
Group’s share %		40	%	40	%	40	%
Group’s share in net assets		144,999		157,149		182,440	​
Goodwill		27,758		27,758		27,758	​
​		172,757		184,907		210,198	​
Less: impairment charges on associates		—		—		(10,998)	​
Carrying amount		172,757		184,907		199,200	​

​

Schedule of Investment in joint venture and percentage of equity interest held in joint venture

​

​	​	​	​	​	​	​
​		For the year ended December 31,
​		2020		2021		2022
​	​	RMB’000	​	RMB’000	​	RMB’000
​	​	​	​	​	​	​
At beginning of year	​	3,705	​	2,976	​	439
Additions	​	2,040	​	—	​	—
Share of losses of joint venture	​	(2,924)	​	(2,204)	​	(439)
Exchange difference	​	155	​	(333)	​	—
At end of year	​	2,976	​	439	​	—

​

X

- Definition

The disclosure of additional information that is not presented elsewhere in the financial statements, but that is relevant to an understanding of them.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfAdditionalInformationExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of joint ventures. [Refer: Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B4
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfJointVenturesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of associates. [Refer: Associates [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B4
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration